| Cavia porcellus |
Kappa opioid receptor |
pD2 |
6.49 |
None |
10.1007/s00044-010-9471-6 |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bile salt export pump |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Bile salt export pump |
IC50 |
135000.0 |
nM |
10.1093/toxsci/kfq269 |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 2 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin B receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cytochrome P450 1A2 |
Inhibition |
nan |
% |
10.1021/tx300075j |
| Homo sapiens |
Cytochrome P450 2C19 |
Inhibition |
nan |
% |
10.1021/tx300075j |
| Homo sapiens |
Cytochrome P450 2C9 |
Inhibition |
nan |
% |
10.1021/tx300075j |
| Homo sapiens |
Cytochrome P450 2D6 |
Ratio IC50 |
2.0 |
None |
10.1021/tx300075j |
| Homo sapiens |
Cytochrome P450 3A4 |
Inhibition |
nan |
% |
10.1021/tx300075j |
| Homo sapiens |
Delta opioid receptor |
AC50 |
180.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Delta opioid receptor |
Ki |
12.0 |
nM |
10.1016/j.bmc.2011.03.052 |
| Homo sapiens |
Delta opioid receptor |
Ki |
12.0 |
nM |
10.1016/j.bmcl.2008.07.054 |
| Homo sapiens |
Delta opioid receptor |
Ki |
12.0 |
nM |
10.1016/j.bmcl.2008.10.134 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Endothelin receptor ET-A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Ghrelin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HERG |
AC50 |
12000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Homo sapiens |
CL |
41.0 |
mL.min-1.kg-1 |
10.1021/jm900403j |
| Homo sapiens |
Homo sapiens |
CL_renal |
2.05 |
mL.min-1.kg-1 |
10.1021/jm900403j |
| Homo sapiens |
Homo sapiens |
DILI_Concern |
nan |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
DILI_severity_class |
0.0 |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
25.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Kappa opioid receptor |
Activity |
nan |
None |
10.1016/j.bmcl.2008.10.134 |
| Homo sapiens |
Kappa opioid receptor |
EC50 |
2.9 |
nM |
10.1016/j.bmcl.2008.10.134 |
| Homo sapiens |
Kappa opioid receptor |
Emax |
73.0 |
% |
10.1016/j.bmcl.2008.10.134 |
| Homo sapiens |
Kappa opioid receptor |
Ki |
0.12 |
nM |
10.1016/j.bmc.2011.03.052 |
| Homo sapiens |
Kappa opioid receptor |
Ki |
0.12 |
nM |
10.1016/j.bmcl.2008.07.054 |
| Homo sapiens |
Kappa opioid receptor |
Ki |
0.22 |
nM |
10.1016/j.bmcl.2008.10.134 |
| Homo sapiens |
Liver microsomes |
Activity |
nan |
None |
10.1021/tx300075j |
| Homo sapiens |
Liver microsomes |
Stability |
nan |
% |
10.1021/tx300075j |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Motilin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Multidrug resistance-associated protein 4 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
6.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
Emax |
22.0 |
% |
10.1016/j.bmcl.2008.10.134 |
| Homo sapiens |
Mu opioid receptor |
IC50 |
14.0 |
nM |
10.1016/j.bmcl.2008.10.134 |
| Homo sapiens |
Mu opioid receptor |
Imax |
54.0 |
% |
10.1016/j.bmcl.2008.10.134 |
| Homo sapiens |
Mu opioid receptor |
Ki |
0.12 |
nM |
10.1016/j.bmcl.2008.10.134 |
| Homo sapiens |
Mu opioid receptor |
Ki |
0.22 |
nM |
10.1016/j.bmc.2011.03.052 |
| Homo sapiens |
Mu opioid receptor |
Ki |
0.22 |
nM |
10.1016/j.bmcl.2008.07.054 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Pregnane X receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Mus musculus |
Mus musculus |
ED50 |
0.05 |
mg.kg-1 |
10.1021/jm00215a012 |
| Mus musculus |
Mus musculus |
ED50 |
0.051 |
mg.kg-1 |
10.1021/jm00203a003 |
| Mus musculus |
Mus musculus |
ED50 |
0.27 |
mg.kg-1 |
10.1021/jm00203a003 |
| Mus musculus |
Mus musculus |
ED50 |
0.3 |
umol.kg-1 |
10.1021/jm00144a015 |
| Mus musculus |
Mus musculus |
ED50 |
0.34 |
umol.kg-1 |
10.1021/jm00138a015 |
| Mus musculus |
Mus musculus |
ED50 |
0.34 |
umol.kg-1 |
10.1021/jm00138a016 |
| Mus musculus |
Mus musculus |
ED50 |
0.34 |
umol.kg-1 |
10.1021/jm00144a029 |
| Mus musculus |
Mus musculus |
ED50 |
0.34 |
umol.kg-1 |
10.1021/jm00176a013 |
| Mus musculus |
Mus musculus |
ED50 |
0.34 |
umol.kg-1 |
10.1021/jm00186a025 |
| Mus musculus |
Mus musculus |
ED50 |
0.98 |
mg.kg-1 |
10.1021/jm00203a003 |
| Mus musculus |
Mus musculus |
ED50 |
0.98 |
mg.kg-1 |
10.1021/jm00215a012 |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Opioid receptor |
ED50 |
2.0 |
umol.kg-1 |
10.1021/jm00144a029 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
0.04 |
mg.kg-1 |
10.1021/jm00203a003 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
0.04 |
mg.kg-1 |
10.1021/jm00215a012 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
0.27 |
mg.kg-1 |
10.1021/jm00215a012 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
0.43 |
mg.kg-1 |
10.1021/jm00203a003 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
0.43 |
mg.kg-1 |
10.1021/jm00215a012 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
2.0 |
umol.kg-1 |
10.1021/jm00138a015 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
2.0 |
umol.kg-1 |
10.1021/jm00138a016 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
2.0 |
umol.kg-1 |
10.1021/jm00144a015 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
2.0 |
umol.kg-1 |
10.1021/jm00176a013 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
2.0 |
umol.kg-1 |
10.1021/jm00186a025 |
| Rattus norvegicus |
Rattus norvegicus |
Ratio |
0.17 |
None |
10.1021/jm00176a013 |
| Rattus norvegicus |
Rattus norvegicus |
Ratio |
0.17 |
None |
10.1021/jm00186a025 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| None |
ADMET |
CL |
41.0 |
mL.min-1.kg-1 |
10.1124/dmd.108.020479 |
| None |
ADMET |
Fu |
0.18 |
None |
10.1021/jm030408h |
| None |
ADMET |
MRT |
5.3 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
T1/2 |
4.8 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
Vdss |
8.8 |
L.kg-1 |
10.1021/jm030408h |
| None |
ADMET |
Vdss |
12.0 |
L.kg-1 |
10.1124/dmd.108.020479 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Index Value |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Active |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Marginal |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Index Value |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
HepSE_bilirubinemia |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholecystitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholelithiasis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cirrhosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_Combined Scores |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_elevated liver function tests |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic failure |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic necrosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatomegaly |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_jaundice |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver disease |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver fatty |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver function tests abnormal |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
LDH Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LDH Increase - Index Value |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LDH Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Index Value |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Index Value |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
NON-PROTEIN TARGET |
Fu |
0.17 |
None |
10.1124/dmd.108.020479 |
| None |
No relevant target |
pKa |
8.19 |
None |
10.1007/s11095-013-1232-z |
| None |
No relevant target |
pKa |
8.19 |
None |
10.1021/jm030408h |
| None |
No relevant target |
Solubility |
500000.0 |
nM |
10.1016/j.bmcl.2010.10.068 |
| None |
Phospholipidosis |
Phospholipidosis |
nan |
None |
10.1080/15376510701857262 |
| None |
Unchecked |
Ratio Ki |
0.55 |
None |
10.1016/j.bmcl.2008.10.134 |
| None |
Unchecked |
Ratio Ki |
1.0 |
None |
10.1016/j.bmcl.2008.07.054 |
| None |
Unchecked |
Ratio Ki |
2.0 |
None |
10.1016/j.bmc.2011.03.052 |
| None |
Unchecked |
Ratio Ki |
2.0 |
None |
10.1016/j.bmcl.2008.07.054 |
| None |
Unchecked |
Ratio Ki |
50.0 |
None |
10.1016/j.bmcl.2008.10.134 |
| None |
Unchecked |
Ratio Ki |
100.0 |
None |
10.1016/j.bmc.2011.03.052 |
| None |
Unchecked |
Ratio Ki |
100.0 |
None |
10.1016/j.bmcl.2008.07.054 |